NCT00144209View on ClinicalTrials.gov

Assess Efficacy and Safety of the Dopamine Agonist Pramipexole Versus Levodopa / Benserazide (Madopar® DR) in Patients With Restless Legs Syndrome

PHASE3CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions
Restless Legs Syndrome
Interventions
DRUG

pramipexole

DRUG

levodopa in combination with benserazide

Trial Locations (6)

3000

Boehringer Ingelheim Investigational Site, Bern

4025

Boehringer Ingelheim Investigational Site, Basel

4031

Boehringer Ingelheim Investigational Site, Basel

5330

Boehringer Ingelheim Investigational Site, Bad Zurzach

8091

Boehringer Ingelheim Investigational Site, Zurich

CH-6900

Boehringer Ingelheim Investigational Site, Lugano

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY